Hyundai Bioscience
048410.KQ
7.89 USD
0.44
+5.91%
h
Overview
Last close
7.89 usd
Market cap
378.86M usd
52 week high
17.93 usd
52 week low
6.33 usd
Target price
N/A usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
47.5753
Price/Book Value
4.1877
Enterprise Value
318.17M usd
EV/Revenue
40.7452
EV/EBITDA
-64.6317
Key financials
Revenue TTM
7.81M usd
Gross Profit TTM
6.70M usd
EBITDA TTM
-2.87M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
96.62M usd
Net debt
N/A usd
About
Hyundai Bioscience Co., Ltd. operates as a biotechnology company. The company provides Vitabrid C12, a vitamin C product that delivers active vitamin C into the skin. It develops Polytaxel, a drug for pancreatic cancer and solid tumors; and CP-COV03 drug for Covid 19. The company was founded in 2000 and is based in Seoul, South Korea.
- Symbol048410.KQ
- ExchangeKQ
- IsinKR7048410005
- CountrySouth Korea
- SectorHealthcare
- IndustryBiotechnology
- CEOJong-Won Choi
- HeadquarterSeoul
- Web sitehttps://www.hyundaibioscience.com
Related indices
Related news
December 13
JAKOTA Stocks on December 13, 2023 November 3
JAKOTA Stocks on November 3, 2023 